
Sign up to save your podcasts
Or
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.
5
77 ratings
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.
1,064 Listeners
31 Listeners
275 Listeners
309 Listeners
337 Listeners
389 Listeners
124 Listeners
316 Listeners
196 Listeners
83 Listeners
86 Listeners
432 Listeners
145 Listeners
17 Listeners
73 Listeners